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Signal transducers and transcription factors are used in common for developmental cell migration, vasculogenesis, branching morphogenesis,
as well as neuronal pathfinding. STAT3, a transcription factor, has been shown to function in all of these processes except neuronal pathfinding.
Here, it is shown that STAT3 also facilitates this process. Elimination of STAT3 signaling results in half of zebrafish CaP motoneurons stalling
along their ventral pathfinding trajectory. Conversely, constitutive activation leads to precocious branching and redefines CaP axons as a
responding population to dorsal guidance cues, resulting in bifurcated axons innervating normal ventral targets as well as additional dorsal muscle
groups. These results are consistent with and highlight a fundamental role for STAT3 as a factor promoting cellular responses to guidance cues, not
only in nonneural cells but also in pathfinding neurons.
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Several signaling components are used in common by cell
migration, vasculogenesis, branching morphogenesis, as well as
neuronal pathfinding. These factors include both intracellular
signaling molecules such as Rho GTPases, as well as
extracellular morphogens, for example, the Wnts, required for
planar cell polarity, cell migration during gastrulation, and later
found to direct dorso-ventral axon projections within the spinal
cord (reviewed in Charron and Tessier-Lavigne, 2005). Another
example, Netrin, was first discovered for its role in neuronal
pathfinding and later found to regulate cell migration (Hedge-
cock et al., 1990; Ishii et al., 1992; Serafini et al., 1994, 1996;
Yebra et al., 2003), vasculogenesis (Weinstein, 2005), and
branching morphogenesis (Liu et al., 2004). This common use
of signaling factors reflects, at the most basic level, common
mechanisms regulating cellular polarization, adhesion, and
cytoskeletal dynamics. The mechanistic similarities between
cell migration/polarization and neuronal pathfinding/growth
cone dynamics were reviewed by Brose and Tessier-Lavigne
(2000) and recently by Arimura and Kaibuchi (2005).E-mail address: gconway@mail.arc.nasa.gov.
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doi:10.1016/j.ydbio.2006.04.444Several findings suggested that JAK1/STAT3 signaling
might function in neuronal pathfinding and in particular for
the pathfinding of a specific subtype of primary motoneuron
called the CaP in the model organism, the zebrafish. STAT3 is a
transcription factor activated by numerous growth factors,
cytokines, and neurotrophic factors (reviewed in O'Shea et al.,
2002). Many of these do so by activating JAK kinase through
receptor dimerization, leading to tyrosine phosphorylation of
STAT3. In addition, extracellular factors can lead to STAT3
phosphorylation by Src and receptor tyrosine kinases. Phos-
phorylation of STAT3 leads to dimerization, retention in the
nucleus, binding to specific DNA sequences, and activation of
target genes.
The fact that numerous neurotrophic factors signaling
through JAK1 and STAT3 function as guidance cues for
motoneurons suggests that JAK1 and STAT3 might function in
motoneuron pathfinding. These factors include CNTF family
members (Helgren et al., 1994; Pennica et al., 1996; Senaldi et
al., 1999; Lelievre et al., 2001; Plun-Favreau et al., 2001;
Derouet et al., 2004) as well as the receptor for the neurotrophic
factor Cxcl12/SDF1 (Vila-Coro et al., 1999; Zhang et al., 2001;
Ahr et al., 2005; Lieberam et al., 2005). The Cxcl12 receptor,
Cxcr4, is expressed on the axons of vertebrate motoneurons and
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2005). C-Ret, the receptor for the neurotrophic factor GDNF,
also activates STAT3, regulates dorsal–ventral pathway choice
of limb motoneurons, and is expressed by the zebrafish CaP
primary motoneuron (Bisgrove et al., 1997; Schuringa et al.,
2001; Kramer et al., 2006).
Likewise, the tyrosine kinase c-Met, the receptor for the
neurotrophic factor HGF/SF, activates STAT3. HGF/SF is
required for vertebrate motoneuron pathfinding (Ebens et al.,
1996; Boccaccio et al., 1998; Caton et al., 2000; reviewed in
Birchmeier et al., 2003). In the zebrafish, HGF/SF is expressed
by somitic muscle (Haines et al., 2004), and c-Met is expressed
specifically by the zebrafish CaP motoneuron at precisely the
time when pathfinding of this neuron begins, but not by other
primary motoneuron subtypes (Segawa et al., 2001). In addition
to the canonical ligand/receptor induced activation of STAT3,
ligand-independent and ligand-potentiated activation of STAT3
can be mediated by LIM-HD proteins (Hao et al., 2005). During
development, LIM-HD proteins are expressed by pathfinding
motoneurons including those of the zebrafish (Inoue et al.,
1994; Tsuchida et al., 1994; Appel et al., 1995; Tokumoto et al.,
1995; Thor et al., 1999).
In vitro studies also support a role for STAT3 in neuronal
pathfinding. The majority of tissue culture studies show that
many cytokines and neurotrophic factors promoting neurite
extension do so through obligate activation of STAT3 (Wu and
Bradshaw, 1996a,b, 2000; Fricker et al., 2005; He et al., 2005;
Kretz et al., 2005; Taylor et al., 2005). If neurite extension and
pathfinding are similar processes requiring a common tran-
scriptional repertoire, then STAT3 likely plays a role during
some neuronal pathfinding processes.
JAK1 and STAT3 also function in cell migration. JAK1 was
the first kinase shown to control the initial morphogenetic
movements that establish the vertebrate body plan (Conway et
al., 1997). Subsequently, STAT3 was also found to be required
for cell movements of vertebrate gastrulation (Takeda et al.,
1997; Yamashita et al., 2002; reviewed in Hou et al., 2002). In
Drosophila, JAK/STAT signaling facilitates cell migration of
ovarian border cells (Silver and Montell, 2001; Beccari et al.,
2002; Ghiglione et al., 2002; Xi et al., 2003). In cell migration,
JAK/STAT signaling functions as a competence factor, defining
the migrating cell population and enhancing migratory
responses to chemotactic cues (Silver and Montell, 2001; Xi
et al., 2003; Silver et al., 2004, 2005). STAT signaling is thought
to provide chemotactic competence by modulating cell
adhesion and cytoskeletal dynamics (Lecomte et al., 1998;
Niewiadomska et al., 1999; Silver and Montell, 2001; Zhang
et al., 2003; Silver et al., 2004, 2005).
Like JAK/STAT, the transcription factors SRF and MAL
have similar functions in border cell migration (Somogyi and
Rorth, 2004). The conservation of signaling molecules in cell
migration and neuronal pathfinding led Knoll et al. (2006) to
investigate the role of SRF and MAL in neuronal pathfinding,
finding that SRF and MAL control pathfinding, branching,
and target selection in the hippocampus. Using the same
reasoning as well as the previously mentioned role of JAK1
and STAT3 in neurotrophic signaling and neurite extension, Iinvestigated the role of JAK1 and STAT3 in neuronal
pathfinding.
During development of the zebrafish neuromuscular system,
STAT3 facilitates pathfinding of the zebrafish CaP primary
motoneuron to peripheral muscle targets. In the absence of
STAT3 signaling axons often stall. Conversely, constitutive
activation of STAT3 results in precocious branching as well as
pathfinding of an ectopic collateral along an alternate motoneu-
ron trajectory. This results in a bifurcated axon projecting to its
normal target as well as along an ectopic path innervating an
additional muscle group. This is the first report of a role for
STAT3 in neuronal pathfinding despite mounting evidence
suggesting this function. The studies presented here uncover a
novel function for STAT3 in facilitating neuronal pathfinding,
the control of axon branching, and in target selection.Methods and methods
Animals and embryo injections
Adult zebrafish of the AB strain and embryos were maintained at 28.5°C.
The zebrafish STAT3 gene was amplified by PCR from gastrula stage (8 h post-
fertilization, p.f.) RNA and cloned into the pSP64T vector upstream from the
EGFP gene to create transcription vectors. The STAT3 gene was sequenced to
verify there were no sequence errors. Site-directed mutagenesis was performed
with the QuickChange site-directed mutagenesis kit (Stratagene, product
200518) and mutagenized clones verified by sequencing. One-cell embryos
were injected with 0.5 nl of a solution containing RNA or morpholinos in a final
concentration of 0.1 M KCl and one quarter diluted phenol red solution (Sigma
Inc., product P-0290). Capped RNA was synthesized with the Ambion
mmessage machine as described by the manufacturer (Ambion Inc., product
1340). Embryos were injected with 125 pg of RNA. Morpholinos were
purchased from GeneTools LLC (Philomath Oregon). The sequence of the
STAT3 morpholino was 5′-CATGTTGACCCCTTAATGTGTCGCT-3′. The
sequence of the JAK1 morpholino was 5′-GACACTCGCCAGGCAAAGC-
TACTTC-3′. Embryos were injected with 2.25 ng STAT3 morpholino or JAK1
morpholino. Peptides were synthesized by Anaspec Inc. (San Jose, CA) and
dissolved in water at three concentrations: 4 ng/nl, 400 pg/nl, or 40 pg/nl. They
were then diluted into injection buffer as described above so that injection of
0.5 nl delivered 1 ng, 100 pg, or 10 pg to injected one-cell embryos.
Immunohistochemistry and in situ hybridization
Embryos were stained with the ZNP1 monoclonal antibody (Developmental
Studies Hybridoma Bank, University of Iowa) at a 1:200 dilution of the ZN5
monoclonal antibody (Antibody Facility, University of Oregon) at a 1:250
dilution as described by Zeller and Granato, 1999). For quantitation of
pathfinding defects, embryos at the same developmental stage (possessing 22
motoneurons per side that had at least reached the choice point) were compared.
GFP signals were amplified and visualized by staining with anti-GFP rabbit
antibody used at a 1:200 dilution (Molecular Probes Inc., product A-6455).
FITC conjugated secondary donkey anti-rabbit IgG was obtained from Jackson
Immunoresearch (product 711-095-152). Anti-phospho-STAT3 antibody stain-
ing (MBL Inc., product D128-3) was performed at a 1:200 dilution and
visualized with the tyramide-alexafluor 488 kit as described by the manufacturer
(Molecular Probes Inc., product T-20912). For dual staining with ZNP1 and
antiphospho-STAT3, the ZNP1 staining was visualized with zenon mouse anti-
IgG2a alexafluor 546 (Molecular Probes Inc., product Z-25104). Following
antibody staining, embryos were equilibrated in 70% glycerol, manually
deyolked and mounted between two coverslips on aluminum cover slide holders
(Harvard University Biological Laboratories Machine Shop). TUNEL staining
was performed with the In Situ Cell Death Detection Kit (Roche, product
2156792) as described by the manufacturer. In situ hybridization was performed
as described by Jowett (Jowett, 1999).
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Cell transplantation chimeras
Donor cells were labeled with rhodamine dextran amine as described (Kane
and Kishimoto, 2002) or by injection of 125 pg of EGFP encoding RNA. Cell
transplantation of donor cells into hosts was performed exactly as described by
Kane and Kishimoto (2002).
Neurospecific promoter expression
STAT3 coding sequences were cloned into the transcription vector
pTAGUMGATA2 (Conway et al., 2006). For mosaic expression analysis, linear
DNA for injection was obtained by PCR using vector primers flanking the
GATA2-STAT3-EGFP insertion. One-cell embryos were injected as described
above with 2.5 pg DNA of the PCR products. Construction of pTAGUMGATA2
and its use in mosaic analysis is described in more detail in Conway et al. (2006).
Imaging, post-image processing, and morphometry
Embryos were imaged at lowmagnification with a Leica MZFLIII dissecting
microscope. Embryos were imaged at high magnification with an inverted Leica
DMIRB and z-stacks taken with Metamorph Software (Universal Imaging Inc.).
Z-stacks were deconvolved using Huygens deconvolution software (Scientific
Volume Imaging Inc.) and viewed with Imaris Software (Bitplane AG).
Branch quantitation
In Fig. 3M, the number and length of branches for CaP motoneurons in
somites 8 through 12 inclusive were measured. Branch lengths were measured
using the measurement function found in the Metamorph software suite. The
CaP axons of only these somites were counted because the CaP projections of
somites 1 through 7 (rostral somites) are already more branched than those in
other somites making measurements difficult. Only branches longer than 4 μm
were included in this analysis, since varicosities in the main axonal trunk of CaP
motoneurons (somites 8–12 inclusive) can be as wide as 3 μm. Only branches
ventral to the choice point were counted.
Results
Morpholino knockdown of STAT3 results in pathfinding defects
To assess the role of JAK1 and STAT3 signaling in the
pathfinding of zebrafish primary motoneurons, one-cell embry-
os were injected with morpholinos (MO) designed to knock-
down signaling by JAK1 or STAT3. It was first important to
confirm that the JAK1MO and STAT3MO prevent signaling of
their respective target genes. Therefore, embryos were exam-
ined for the appearance of an easily visualized, extensively
studied, and characteristic morphotype of JAK1/STAT3 inhibi-
tion: reduction in the extension of anterior axial mesendoderm.
If the morpholinos inhibit JAK1/STAT3 signaling, then these
embryos should display these defects. The anterior mesendo-
dermal defects resulting from JAK1/STAT3 inactivation result
in a morphologically distinct shortening of the anterior axis
resulting in fore and mid-brain defects (Conway et al., 1997;
Yamashita et al., 2002). Shown in Figs. 1F and Q, fore and mid-
brain defects are produced upon JAK1 MO and STAT3 MO
injection compared to uninjected embryos (Fig. 1C), in
agreement with previous reports (Conway et al., 1997;
Yamashita et al., 2002). Also, the specific inhibition of JAK1
kinase is confirmed by the ability of reintroduced wild-type
JAK1 to rescue axis defects caused by the JAK1 MO (not
shown).Examining MO injected embryos with a phospho-STAT3
specific antibody and comparing these to uninjected embryos
further confirmed the effect of the STAT3 MO upon STAT3
signaling. This antibody specifically interacts with the
phosphorylated form of zebrafish STAT3 (Yamashita et al.,
2002). Phosphorylated STAT3 is found in a random set of EVL
cells, a form of skin covering the embryo, and in spinal cord
neurons and the eye of 27-h p.f. uninjected embryos (Figs. 1I–
K). The STAT3 MO reduces the number of STAT3-PO4-
positive cells in the eye to 17% and in the spinal cord to 10%
of uninjected embryos (Figs. 1L–N), confirming inhibition of
STAT3 signaling caused by the morpholino injection. Compare
the abundance of EVL expressing cells in an uninjected
embryo (Fig. 1O) to that of a STAT3 MO injected embryo
(Fig. 1P).
Motoneuron development in the zebrafish is simple
compared to neuromuscular development in other model
organisms. At 17 h post-fertilization (p.f.), four neurons in
each hemisegment, designated as motoneuron subtypes, project
axons that fasciculate and together exit the spinal cord. These
axons travel along the medial somitic muscle surface to a point
between the dorsal and ventral muscle groups called the choice
point, where after a 2-h pause, the MiP and CaP subtypes
project along subtype specific paths to the respective dorsal or
ventral muscle groups (Fig. 1A). The RoP projects no further,
eventually sending small branches rostral and caudal between
the dorsal and ventral muscles. The VaP motoneuron is
randomly present in roughly half of all hemisegments, projects
no further than the choice point, and dies between the first and
second day of development.
With confirmation that the morpholinos inhibit JAK1 or
STAT3 signaling, the primary motoneuron projections in these
embryos were examined and compared to uninjected embryos.
In all experiments reported herein, unless otherwise noted,
embryos were examined at 27 h p.f. Motoneuron pathfinding
occurs in a rostral to caudal sequence and at 27 h p.f., the
primary motoneurons in roughly half of all somites have
completed pathfinding to the dorsal and ventral targets (Fig. 1A)
while half are in the process of pathfinding along subtype
specific trajectories. Thus, by examining embryos at this stage,
one can visualize in the same embryo the full kinetics of
motoneuron pathfinding to the ventral and dorsal targets.
Motoneurons projections were revealed by staining with a
motoneuron-specific antibody (ZNP1 antibody). JAK1 MO
injected embryos (Fig. 1S) possess normal dorsal (white
arrowheads) and ventral (black arrows) motoneuron projec-
tions, identical to uninjected embryos (Fig. 1D). However,
pathfinding of CaP motoneurons in STAT3 MO injected
embryos (Fig. 1G) is stalled or delayed (black arrows) at or
shortly beyond the choice point (black arrowheads) while MiP
dorsal projections (white arrowheads) are normal. Pathfinding
was not assessed in the RoP because its axon fasciculates with
axons of the MiP and CaP.
To quantitate pathfinding defects, CaP axons were classified
into one of three types (as illustrated in Fig. 1G and
schematically shown in Fig. 1B): (type 1 neurons) those having
projected to the ventral target (type 2 neurons), those having
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ventral target, and (type 3 neurons) those not having projected
past the choice point. This quantitation scheme is also used in
Figs. 2 and 3. At 27 h p.f., type 2 and 3 neurons are confined to
caudal somites of uninjected (Fig. 1E) and JAK1 MO injected
embryos (Fig. 1T). In STAT3 knockdown embryos (Fig. 1H)
CaP motoneurons often fail to project past the choice point or
stall shortly after projecting along the ventral pathway; type 2and 3 neurons are found in rostral as well as caudal somites. To
determine if CaP motor axons are either stalled or delayed, MO
injected embryos at 2 and 3 days p.f. were stained with the
ZNP1 antibody and CaP axons examined (examples shown in
Figs. 7J, M, P). Even after three days p.f. ventrally projecting
CaP axons do not arrive at the ventral target, indicating that that
CaP axons are stalled rather than delayed in their projection
along the ventral pathway.
Fig. 2. Blocking peptides result in pathfinding failures. In panels B, E, and H, black arrowheads mark the choice point and black arrows mark the most ventral
extension of the CaP motoneuron axon. (A–C) Analysis of control peptide injected embryos. (A) Whole body image of an embryo injected with the control peptide
showing the normal body axis. (B) Normal primary motoneuron projections. (C) Quantitation of CaP neural types in control peptide injected embryos, showing type 2
and 3 neurons confined to caudal somites as in uninjected embryos. (D–F) Analysis of embryos injected with phosphotyrosine containing peptide. (D) Whole body
image of an embryo injected with the phosphotyrosine containing peptide showing foreshortened anterior axis with subsequent fore and mid-brain defects. (E) Primary
motoneuron projections showing forestalled ventral CaP axon projections. (F) Quantitation of CaP neural types showing stalled type 2 and 3 neurons in rostral as well
as caudal somites. (G–I) Analysis of embryos injected with phosphomethyl-Phe containing peptide. (G) Whole body image showing foreshortened anterior axis with
subsequent fore and mid-brain defects. (H) Primary motoneuron projections showing forestalled ventral CaP axon projections. (I) Quantitation of CaP neural types
showing stalled type 2 and 3 neurons in rostral as well as caudal somites. In all images, rostral is to the left, and dorsal is up.
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defects, JAK1 signaling was eliminated or reduced in
morpholino injected embryos. Therefore, it is unlikely that
the MO failed to affect motoneuron pathfinding because thereFig. 1. Morpholino (MO) Inactivation of STAT3, but not JAK1, causes Pathfinding
arrowheads the choice point, black arrows mark the most ventral extension of the
zebrafish showing motoneuron subtypes: RoP, MiP, CaP, and VaP, and their axon pro
pathfinding used in quantitations shown in panels E, H, G, T, and in Figs. 2 and 3. (
embryo showing the normal body axis. (D) Normal primary motoneuron projection
embryos, showing type 2 and 3 neurons confined to caudal somites. (F–H) Analysis o
embryo showing foreshortened anterior axis with subsequent fore and mid-brain defec
a morphotype of STAT3 inactivation. (G) Primary motoneuron projections in a STA
Quantitation of CaP neural types in STAT3 MO embryos showing stalled type 2 an
STAT3 in uninjected and STAT3 MO injected embryos. (I and L) Whole embryo imag
(L) embryos. (J and M) Images of the eye showing phospho-STAT3-positive cells in
spinal cord showing the presence of phospho-STAT3 containing neurons in uninject
expressing activated STAT3 in an uninjected embryo (O) and reduced cell numbers i
DN-JAK1 expressing embryos. (Q) Whole body image of a JAK1 MO injected em
defects. These defects result from reduced anterior axial mesendoderm cell migration
JAK1 expressing embryo showing anterior axis defects identical to that see in panel
showing normal axonal trajectories. Pathfinding is also unaffected in DN-JAK1 ex
embryos, showing type 2 and 3 neurons confined to caudal somites as is seen for
embryos. In all images, rostral is to the left, and dorsal is up.is no inhibition of JAK1 function. However, to confirm this
negative result, an additional approach was used to disrupt
JAK1 signaling. One-cell embryos were injected with RNA
encoding a dominant negative version of JAK1 kinase (DN-defects. In panels D, G, and S, white arrowheads mark dorsal projections, black
CaP motoneuron axon. (A) Schematic diagram of primary motoneurons in the
jections. (B) Schematic diagram of CaP neural types based upon extent of axon
C–E) Analysis of uninjected embryos. (C) Whole body image of an uninjected
s in an uninjected embryo. (E) Quantitation of CaP neural types in uninjected
f STAT3 MO injected embryos. (F) Whole body image of a STAT3 MO injected
ts. These defects result from reduced anterior axial mesendoderm cell migration,
T3 MO injected embryo showing forestalled ventral CaP axon projections. (H)
d 3 neurons in rostral as well as caudal somites. (I–P) Comparison of activated
es of phospho-STAT3 containing cells in uninjected (I) and STAT3 MO injected
uninjected (J) and STAT3 MO injected (M) embryos. (K and N) Images of the
ed (K) and STAT3 MO injected (N) embryos. (O and P) Close up of EVL cells
n a STAT3 MO injected embryo (P). (Q–T) Analysis of JAK1 MO injected and
bryo showing foreshortened anterior axis with subsequent fore and mid-brain
, a morphotype indicative of JAK1 inactivation. (R) Whole body image of a DN-
Q above. (S) Primary motoneuron projections in a JAK1 MO injected embryo,
pressing embryos. (T) Quantitation of CaP neural types in JAK1 MO injected
uninjected embryos. Identical results were obtained for DN-JAK1 expressing
124 G. Conway / Developmental Biology 296 (2006) 119–136JAK1). This altered JAK1 protein possesses a single amino
acid substitution in the kinase domain and has previously been
shown to be kinase inactive and to function as a dominantnegative leading to anterior axis defects that can be rescued by
reintroduction of wild-type JAK1 kinase (Fig. 1R and Conway
et al., 1997). As with the JAK1 MO injection, no effect was
125G. Conway / Developmental Biology 296 (2006) 119–136seen upon pathfinding of dorsal or ventral projecting axons
(not shown).
These results show a STAT3 requirement for pathfinding of
the CaP motoneuron beyond the choice point. The observation
that neither the JAK1 MO nor DN-JAK1 expression affected
pathfinding indicates that either JAK1 kinase is not required or
residual activity is sufficient for motoneuron pathfinding, even
though this level of JAK1 signaling is insufficient for axial
mesendoderm migration. Also the presence of anterior axis
defects in embryos with both normal CaP projections (JAK1
MO and DN-JAK1 injected) and foreshortened CaP projections
(STAT3 MO injected) suggest that the anterior axis defect does
not in itself lead to pathfinding failure.
Blocking peptides confirm a role for STAT3 in motoneuron
pathfinding
To confirm the role of STAT3 in motoneuron pathfinding,
an additional approach was used to inhibit STAT3 function.
This additional approach, the injection of blocking peptides,
inhibits STAT3 signaling at a step different from that targeted
by morpholinos. While morpholinos inhibit STAT3 produc-
tion and ultimately levels of phospho-STAT3, blocking
peptides have no effect upon STAT3 levels, instead they
inhibit STAT3 dimerization. STAT3 is activated by phosphor-
ylation of a tyrosine residue on a flexible unstructured loop,
called the activation loop, that interacts with the SH2 domain
of an adjacent STAT3 monomer. Interaction of the SH2
domain with this loop sequence is dependent upon tyrosine
phosphorylation. By mutual SH2-phosphoactivation loop
interactions, two STAT3 monomers are linked into a
functional dimer capable of transactivating target genes.
Blocking peptides are short amino acid sequences comprising
the activation loop sequence, either possessing a phosphotyr-
osine or as a control substituting the tyrosine with
phenylalanine. Injected at the one-cell stage, the phosphotyr-
osine containing peptide should occupy STAT3 SH2 domains
preventing STAT3 dimerization. This approach was previous-
ly used by Boccaccio et al. (1998) to confirm the essential
role of STAT3 in the induction of branching morphogenesis
induced by HGF/SF.Fig. 3. Morpholino defects can be rescued, while Dominant negative and Constitutiv
mark the choice point and black arrows mark the most ventral extension of the CaP m
arrows in panel L are mentioned in the Results section on mosaic analysis. (A–D) Res
foreshortened anterior axis with subsequent fore and mid-brain defects. (B) Whole b
wild-type STAT3 with the STAT3 MO. (C) Primary motoneuron projections in an e
pathfinding. (D) Quantitation of CaP neural types showing rescue of pathfinding defec
of embryos expressing DN-STAT3. (E) Whole body image showing foreshortened an
projections showing forestalled ventral CaP axon projections. (G) Quantitation of Ca
somites. (H–K) Confirmation that DN-STAT3 inhibits endogenous signaling by dem
wild-type embryo showing foreshortened anterior axis with subsequent fore and mid
anterior axial mesendoderm. Because these cells contribute to precordal mesendode
noncell autonomous affect during gastrulation is a characteristic of STAT3 signaling
embryo shown in panel H. (J) Whole body image of a wild-type embryo showing
precordal plate. (K) The donor cells, shown by GFP fluorescence, positioned more pos
blastomeres. (L and M) Constitutive activation of STAT3 leads to exuberant branc
motoneuron axon. (M) Quantitation of branch numbers. Asterisk marks statistical si
Embryos are at 27 h post-fertilization.One caveat to the use of the phosphotyrosine containing
peptide is the potential loss of the phosphate group on the
tyrosine due to phosphatases. Because these peptides are
injected at the one-cell stage, the phosphotyrosine peptide
must remain in the phosphorylated state for at least 17 h within
the embryo until motoneuron pathfinding commences. To
circumvent this potential problem, an additional peptide was
synthesized containing a nonhydrolysable analogue of phos-
photyrosine. This peptide is identical to the control and
phosphotyrosine peptides except for possessing phospho-
methyl-phenylalanine (phosphomethyl-Phe), a nonhydrolyz-
able mimetic of phosphotyrosine.
The ability of blocking peptides to inhibit STAT3 signaling
can be confirmed, just as with the STAT3 MO injection, by the
presence of axial mesendoderm defects. Also, the specificity of
the phosphotyrosine containing peptide should be confirmed by
the inability of the control phenylalanine containing peptide to
inhibit mesendodermal cell migration. Injection of embryos
with the phenylalanine peptide has no effect upon gastrulation
movements, resulting in a normal fore and mid-brain (Fig. 2A).
In contrast, the experimental peptides (containing phosphotyr-
osine or phosphomethyl-Phe) inhibit anterior mesendodermal
migration resulting in reduced anterior structures (Figs. 2D and
G) identical to that produced by the morpholino injection (Fig.
1F) and reported by Yamashita et al. (2002). These defects
confirm the ability of the experimental peptides to inhibit
STAT3 signaling.
Analysis of motoneuron pathfinding reveals normal path-
finding in control peptide injected embryos (Figs. 2B and C).
However, pathfinding of the ventral projecting axon of the CaP
motoneuron is stalled in embryos injected with the phosphotyr-
osine or phosphomethyl-Phe containing peptide (Figs. 2E, F, H,
and I). In these experiments, three concentrations of each
peptide were investigated, each differing by a 10-fold
concentration. Even the lowest concentration of the phospho-
tyrosine containing peptide inhibited CaP motoneuron path-
finding, while the control peptide at the highest concentration
had no effect.
Though the phosphotyrosine and phosphomethyl-Phe con-
taining peptides both inhibit pathfinding, even at the highest
concentration injected the effect is less than that seen upon MOely Active versions differentially alter Pathfinding. In panel F, black arrowheads
otoneuron axon. In panel L, red arrowheads mark axon branches. White and blue
cue of Morpholino induced pathfinding defects. (A) Whole body image showing
ody image showing rescue of the anterior axis by co-injection of RNA encoding
mbryo injected with RNA encoding wild-type STAT3, showing no affect upon
ts by co-injection of MO with RNA encoding wild-type STAT3. (E–G) Analysis
terior axis with subsequent fore and mid-brain defects. (F) Primary motoneuron
P neural types showing stalled type 2 and 3 neurons in rostral as well as caudal
onstration of nonautonomous cell migration defects. (H) Whole body image of a
-brain defects due to transplantation of DN-STAT3 expressing cells populating
rm, they inhibited migration of neighboring cells along the anterior axis. This
. (I) GFP fluorescence of donor cells populating anterior axial mesendoderm of
normal anterior axis because DN-STAT3 expressing cells did not populate the
terior to those in panels H and I, and thus not inhibiting migration of neighboring
hing. (L) Primary motoneuron projections showing extra branches on the CaP
gnificance (t test, P < 0.05). In all images, rostral is to the left, and dorsal is up.
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produces more severe (more type 3 verses type 2) pathfinding
defects than the phosphomethyl-Phe peptide. The severity of
pathfinding failures correlates with the severity of anterior
mesendoderm defects (note the more severe deficit of fore and
mid-brain in Fig. 2D compared to Fig. 2G). The difference in
the extent of pathfinding failure between the MO and peptide
injections likely reflects a difference in the extent to which
STAT3 signaling is inhibited.
Pathfinding defects are rescued by reintroduction of STAT3
If the pathfinding defects caused by the STAT3 MO result
from specific inhibition of STAT3 signaling, then these defects
should be rescued by the co-injection of the morpholino with
mRNA encoding wild-type STAT3. To generate an mRNA that
encodes STAT3 and is not itself inhibited by the morpholino, the
STAT3 coding sequence was placed into a transcription vector
behind the B-globin 5′-UTR. Because the STAT3 MO is
complementary to 5′ sequence in the STAT3 transcript, the MO
should be unable to hybridize to the synthetic mRNA and
inhibit protein synthesis from this transcript. This RNA also
possessed the coding sequence of EGFP in frame and
downstream from the STAT3 coding sequence. This EGFP
fusion is useful in confirming that the MO does not inhibit
protein synthesis from this RNA, indicated by the presence of
GFP fluorescence, and is important as a cell labeling technique
in experiments that will be detailed later in the results section.
The ability of the synthetic mRNA to rescue STAT3
signaling was confirmed by the rescue of anterior axial defects.
As shown in Fig. 3A, previously in Fig. 1F, and by Yamashita et
al. (2002), the STAT3 MO leads to fore and mid-brain defects.
However, if the STAT3-EGFP RNA is co-injected with the MO,
cell migration defects are rescued (Fig. 3B). This rescue was
also shown by Yamashita. The inability of the MO to inhibit
protein synthesis from this RNA is confirmed by GFP
fluorescence (not shown). To examine if this rescue extends
to pathfinding defects, it was first essential to show that STAT3
expression does not in itself affect pathfinding. Motoneuron
pathfinding in embryos injected with just the STAT3-EGFP
RNAwas examined, and no effect upon pathfinding was found
(Fig. 3C). Next, pathfinding in embryos co-injected with the
MO and STAT3-EGFP RNAwas examined and CaP motoneu-
ron pathfinding was rescued. Type 2 and 3 projections were
confined to caudal somites (Fig. 3D), just as is seen in
uninjected embryos (Fig. 1E).
Dominant negative STAT3 expression confirms the role of
STAT3 in motoneuron pathfinding
As with the JAK1 experiments shown in Figs. 1Q and R, a
dominant negative was also used as an additional approach to
inhibit signaling, in this case to confirm STAT3 morpholino
results. The dominant negative approach, like the MO and
blocking peptide methods, inhibits STAT3 signaling at a unique
step in the eventual formation of STAT3 dimers. The DN-
STAT3 mutant was constructed by changing the tyrosine in theactivation loop sequence to phenylalanine. Numerous studies in
other model systems have shown this version of STAT3 to
function as a dominant negative preventing STAT3 signaling
(Kaptein et al., 1996; Bromberg et al., 1998; Bromberg and
Darnell, 2000). Because the DN-STAT3 can still bind to
receptor docking sites but is unable to undergo tyrosine
phosphorylation, the DN-STAT3 competes with endogenous
STAT3 for receptor interactions preventing kinase activation of
STAT3. For ligand/receptor-independent STAT3 activation,
DN-STAT3 should interact with LIM domains preventing
incorporation of endogenous STAT3 into LIM-HD/kinase/
STAT3 signaling complexes.
As with the MO and blocking peptide methods, the DN-
STAT3 was confirmed to inhibit STAT3 signaling by its effects
upon gastrulation movements. Expression of DN-STAT3 leads
to fore and mid-brain defects (Fig. 3E). In the process of
executing cell transplantation experiments that will be detailed
below and shown in Fig. 4, an additional confirmation that the
DN-STAT3 inhibits STAT3 signaling was obtained. The
requirement for STAT3 in cell migration is specific to anterior
axial mesendoderm and is both cell autonomously and
nonautonomously required. In the course of transplant experi-
ments, blastomeres from DN-STAT3-EGFP expressing embry-
os were transplanted into the embryonic shield of unlabeled host
embryos. The migration and fate of the donor cells can be
followed by virtue of their GFP fluorescence. When these cells
comprise a fraction of the most anterior axial mesendoderm they
inhibit migration of surrounding host cells resulting in a
dramatic reduction in the length of the anterior axis and a
decrease in the size of the fore and mid-brain (Figs. 3H and I).
When a comparable number of transplanted cells populate more
posterior axial mesendoderm there is no effect upon axis
formation (Figs. 3J and K). This nonautonomous effect,
restricted to anterior mesendoderm, is additional confirmation
that the DN-STAT3 version inhibits endogenous STAT3
signaling, a result identical to that shown by Yamashita et al.
(2002) using cell transplants and a STAT3 morpholino.
Examination of motoneuron pathfinding in DN-STAT3
expressing embryos reveals CaP motoneuron pathfinding
defects (Fig. 3F). In these embryos, the extent of pathfinding
failure by the ventral projecting CaP axon is not as severe as that
seen upon MO injection with the majority of failures being type
2 rather than type 3 pathfinding defects (Fig. 3G). As with the
blocking peptide method, this may reflect a less thorough
inhibition of STAT3 signaling than achieved by MO injection.
Constitutive activation of STAT3 results in exuberant
branching of CaP motoneuron axons
If STAT3 signaling is required for CaP motoneuron
pathfinding, will constitutive activation of STAT3 affect
pathfinding? To address this question, a constitutively active
version of STAT3 (CA-STAT3) was constructed by changing
two amino acid residues (for zebrafish STAT3 alanine 663 and
asparginine 665) to cysteines. The crystal structure of the
STAT3 dimer has shown that these residues of each monomer
are closely opposed (Becker et al., 1998). Substitution of
Fig. 4. Mosaic analysis reveals cell autonomous requirements for, and affects of, STAT3 activation upon CaP motoneuron pathfinding. White arrowheads in all panels
mark donor cells that did not differentiate into neurons; most are EVL cells. Panels A–L show embryos at 27 h post-fertilization (p.f.). Embryos in panels M–P are at
48 h p.f. In all images, rostral is to the left, and dorsal is up. (A–L) Cell transplantation chimeras show a cell autonomous requirement for STAT3 in CaP motoneuron
pathfinding and axon bifurcation upon constitutive activation. (A, C, E, G, I, K, and L) Donor motoneurons transplanted into host embryos revealing axon projections
of the donor neurons. (B, D, F, H, and J) ZNP1 staining of primary motoneurons present in the preceding panel. (B) Wild-type donor CaP transplanted into a wild-type
host showing that the transplant technique does not alter axon projections or donor viability. (C) Wild-type donor CaP andMiP showing normal axon paths in a STAT3
MO host. (E) Donor CaP motoneuron expressing wild-type STAT3 showing that STAT3 expression does not alter pathfinding trajectory. (G) Dominant negative
STAT3 expressing CaP motoneuron showing pathfinding failure (open arrowhead) in a wild-type host. (I) Constitutively active STAT3 expressing CaP neuron shows
bifurcated axon projecting both ventrally as well as along the dorsal pathway (arrow). (K) A group of donor motoneurons transplanted into a wild-type host. In no case
did expression of any STAT3 variant affect MiP or RoP axon projections. The RoP and MiP pair enclosed by the dashed circle exemplifies donor neurons that were not
included in any analysis since they occupy the same hemisegment and donor cell–cell interactions cannot be excluded. The lone MiP motoneuron that is labeled is the
only neuron in that hemisegment originating from donor cells and was thus included in cell counts. (L) Representative donor RoP motoneuron. In condition was RoP
pathfinding affected. (M–P) Expression of constitutively active STAT3 from a neurospecific promoter leads to ectopic collateral formation. (M) Normal axon
projection of a CaP motoneuron expressing wild-type STAT3 from a neurospecific promoter. (O) Expression of constitutively active STAT3 produces a bifurcated axon
projecting both ventrally as well as along the dorsal pathway (arrow). (N and P) ZNP1 staining of primary motoneurons present in the preceding panel. (Q–S)
Schematic representation of CaP axon projections shown in the above panels.
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bridged dimer, nuclear localization, and constitutive transcrip-
tional activation of genes (Bromberg et al., 1999; Shen et al.,
2001).
One cell embryos were injected with RNA encoding either
wild-type or CA-STAT3 and motoneurons examined. Expres-
sion of CA-STAT3 leads to exuberant branching of CaP
motoneuron axons (Fig. 3L; red arrowheads), compared to
uninjected (Fig. 1D) or wild-type STAT3 expressing embryos
(Fig. 3C). In uninjected embryos, CaP motoneurons possess on
average 2 branches ventral to the choice point at 27 h p.f. (Fig.
3M). Expression of wild-type STAT3 has no effect upon the
number of branches. However, expression of constitutively
active STAT3 increased this number to an average of 8 branches.
Though the number of branches was increased, the length of the
branches was unchanged (10 μ + 6 μ for uninjected, 10 μ + 5 μ
for STAT3-GFP injected, 8 μ + 3 μ for CA-STAT3-GFP
injected). Though CA-STAT3 increased axonal branching, it did
not affect the extent to which ventral projecting CaP axons
reached the ventral target.
Mosaic analysis reveals a cell autonomous requirement for,
and effect of, STAT3 activation
The results presented so far indicate a role for STAT3 in
pathfinding of the CaP motoneuron. These findings come from
inactivation methods that eliminate or reduce STAT3 signaling
throughout the entire embryo. To determine if the STAT3
requirement is cell autonomously required only in the CaP
motoneuron, in surrounding cells such as muscle targets, or in
both types of cells, cell transplantations were performed to
generate chimeric embryos possessing motoneurons lacking
STAT3 signaling in a wild-type host, as well as wild-type
motoneurons in a host lacking STAT3 signaling. Donor cells
were labeled with rhodamine dextran or detected by GFP
fluorescence if injected with RNA encoding a STAT3-EGFP
version. At the late blastula stage, cells were transplanted from
labeled donor embryos to same-stage hosts and transplanted
according to the zebrafish fate map into regions of the host thatTable 1





# RoPs Normal Abnormal # MiPs No
Chimeras: donor→host
WT→WT 24 12 12 0 8 8
WT→MO 15 13 13 0 9 9
STAT3→WT 14 10 10 0 12 12
DN-STAT3→WT 21 8 8 0 11 11
CA-STAT3→WT 27 9 9 0 12 12
Neurospecific transgene injected
EGFP 489 18 18 0 5 5
STAT3 398 8 8 0 4 4
DN-STAT3 178 5 5 0 5 5
CA-STAT3 427 19 19 0 4 4
Cell transplantation chimeras and TAGUM (Conway et al., 2006) reveal cell autono
target selection.increase the likelihood of donor cells developing into spinal
cord neurons. Transplanted neurons were only included in any
analysis if they were the only neurons within that hemisegment
originating from donor cells. In this way, the possible influence
and contribution of donor cell interactions were eliminated.
To ensure that the transplantation technique is not deleterious
to the survival or pathfinding of donor motoneurons, wild-type
donor cells were transplanted into wild-type hosts (Figs. 4A and
B). When donor cells differentiated into any of the three
motoneuron subtypes, there was no effect upon viability or
axon projections. Results from all transplants are shown in Figs.
4A–L and in Table 1. In no case was there an effect upon
pathfinding of the RoP or MiP motoneuron subtypes. A
representative MiP and RoP are shown in Figs. 4K and L. The
image shown in panel K was especially selected for presentation
because it shows a pair of primary motoneurons, a RoP and MiP
(encompassed by the dashed circle) adjacent to one another in the
same hemisegment that are examples of motoneurons not
included in any analysis. For these two neurons, the potential
contribution of donor–donor interactions cannot be excluded.
The labeled MiP, however (in this case expressing DN-STAT3),
was included in analysis since it is the only neuron in that
hemisegment originating from donor cells. The cells marked with
arrowheads in this and other panels mark nonspinal cord cells that
originated from the donor. In most cases, these were EVL cells.
Only pathfinding of the CaP motoneuron was affected and
only when STAT3 signaling was disrupted (Figs. 4G and H,
open arrowhead denotes stalled CaP axon) or constitutively
activated (Figs. 4 I and J) in the donor CaP motoneuron (Table
1). Expression of wild-type STAT3 (STAT3 donor in panels E
and F) has no effect upon pathfinding. The results of
constitutive activation reveal an unexpected finding. While
branching was more extensive in these axons and expected,
these CaP motoneurons possessed in almost all cases an ectopic
collateral that projected dorsally, along the path taken by the
MiP motoneuron (arrow, Fig. 4I, Table 1). In view of this
finding, a re-examination of pathfinding in embryos injected at
the one-cell stage with RNA encoding CA-STAT3, like that
shown in Fig. 3L, often reveals an additional dorsal projectionCaPs




0 28 28 0 0
0 49 49 0 0
0 12 12 0 0
0 12 7 5 0
0 15 1 0 14
0 18 18 0 0
0 22 22 0 0
0 11 11 0 0
0 21 11 0 10
mous requirements for, and affects of, STAT3 activation upon pathfinding and
129G. Conway / Developmental Biology 296 (2006) 119–136(white arrow) or an axon (probably an ectopic CaP collateral)
crossing over to the dorsal MiP projection (blue arrow).
To determine if there is a critical period during which CaP
motoneurons are susceptible to the effects of STAT3 inhibition
or constitutive expression, DN and CA-STAT3 were expressed
in primary motoneurons after they reached the ventral target.
In the cell transplantation experiments described above, DN
and CA-STAT3 were expressed in motoneurons from before
their commitment to become neurons, through their motoneu-
ron specification, and during the pathfinding process. To affect
expression of DN and CA-STAT3 at a later time, expression
of these STAT3 variants was driven by the mosaic expression
of a neurospecific promoter. This promoter drives expression
in primary motoneurons beginning around 24 h p.f. and in
CaP motoneurons when the ventral projecting axon is
pathfinding between the choice point and ventral target or
has reached the ventral target. This promoter construct and its
use in mosaic analysis have been previously detailed (Conway
et al., 2006).
STAT3 or EGFP expressing neurons were visualized by
virtue of their fluorescence. Results are shown in Table 1 and
Figs. 4M–P. In RoP and MiP motoneurons, no effect was seen
upon pathfinding when wild-type, DN, or CA-STAT3 were
expressed (Table 1). In CaP motoneurons expression of wild-
type STAT3 had no affect (Figs. 4M and N; Table 1). Unlike the
cell transplant mosaics, expression of DN-STAT3 had no affect
upon pathfinding of the CaP motoneuron. This difference
between mosaic neurospecific promoter expression and cell
transplantation may reflect a critical period before extension
along the ventral path or reflect the inability of the expression
level from the neurospecific promoter to adequately disrupt
STAT3 signaling sufficient to affect pathfinding.
The expression of CA-STAT3 from the neurospecific
promoter construct recapitulates the results found by cellFig. 5. Antibody staining for phosphorylated STAT3. (A) Mosaic image of a 27 h p
ZNP1 (red) for primary motoneurons. White arrows mark neuronal cell bodies posi
Higher magnification images of neuronal soma (white arrows) possessing phosphortransplantation. In one half of CaP motoneurons expressing CA-
STAT3 from the promoter construct, an ectopic collateral
formed projecting dorsally along the path followed by the MiP
motoneuron (Figs. 4O and P). The percentage of CaP
motoneurons possessing an ectopic collateral is less than
found by cell transplantation. As with the DN-STAT3
experiment, this may reflect a critical period for collateral
formation or indicate that the levels of CA-STAT3 from the
promoter are insufficient to induce collateral formation in all
CaP motoneurons. In either case, the induction of collateral
formation by CA-STAT3 in the promoter experiments agrees
with the cell transplantation results and confirms the cell
autonomous affect of STAT3 activation upon CaP axon
morphology.
STAT3 is phosphorylated in CaP motoneurons
Consistent with results present so far, it would be expected
that STAT3 is activated in CaP motoneurons. To examine
STAT3 activation, embryos were probed with a phosphospecific
STAT3 antibody to identify the location of activated STAT3.
Phosphorylated STAT3 is not found in all hemisegments. When
present it is found in only one neural soma per hemisegment and
possess a size, shape, and position consistent with CaP
motoneurons (Figs. 5A–D, arrows). Staining was not found in
the RoP, MiP, or muscles. As mentioned for Figs. 1I and O,
phosphorylated STAT3 is also found in random EVL cells that
are seen out-of-focus in Fig. 5A.
Motoneuron specification is unaltered by STAT3 inactivation
Pathfinding defects could result from inappropriate moto-
neuron specification; CaP motoneurons could trans-fate into
RoP or MiP-like neurons. To assess motoneuron specification,.f. embryo stained with an antibody to phosphorylated STAT3 (green) and with
tive for phosphorylated STAT3. Green cells out of focus are EVL cells. (B–D)
ylated STAT3. In all images, rostral is to the left, and dorsal is up.
Fig. 6. Motoneuron specification is unaltered by STAT3 inactivation. Motoneuron specification was assessed by LIM homeodomain expression. In situ hybridization
was performed on uninjected (A and D), STAT3MO injected (B and E), and DN-STAT3-GFP expressing (C and F) embryos. (A–C) In situ hybridization reveals in all
cases two Isl1-positive neurons per hemisegment indicating the specification of one RoP and one MiP per hemisegment. This is inconsistent with the CaP motoneuron
trans-specifying into a RoP or MiP, which would result in a third Isl1-positive neuron found in a hemisegment. (D–F) In all cases, in situ hybridization for Isl2
identifies one (arrowheads) or two neurons (asterisk) per hemisegment consistent with the CaP and the variably present VaP. In all images, rostral is to the left, and
dorsal is up. Embryos are at 27 h post-fertilization.
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Islet 2 transcription factors. At 27 h p.f., Islet 1 is a molecular
marker of RoP and MiP specification, while Islet 2 is expressed
by CaP and ViP motoneurons. The distribution of Islet 1 and 2
expressing motoneurons in embryos injected with the STAT3
MO or RNA encoding DN-STAT3 is indistinguishable from
uninjected embryos suggesting that motoneurons, especially
CaPs, are properly specified (Fig. 6; arrowheads).
STAT3 morpholino and dominant negative expression do not
lead to motoneuron apoptosis
An additional explanation for pathfinding defects is the
possibility that elimination of STAT3 signaling leads to
neuronal apoptosis. To investigate cell death in these treated
embryos, TUNEL staining was performed over a develop-
mental time course, and motoneurons were visualized byFig. 7. STAT3 inactivation does not induce cell death of primary motoneurons. (A–
apoptosis by TUNEL as well as for primary motoneurons using the ZNP1 monoclo
encompassing motoneuron soma is demarcated between dashed lines. In the spina
positioned in the dorsal spinal cord above the dashed lines (white arrows). Occasiona
motoneuron soma (red arrow). (J–R) STAT3 morpholino injected embryos stained
injection. The most ventral axon position of CaP motoneurons that failed to reach the
also obtained upon dominant negative DN-STAT3-GFP expression (not shown). InZNP1 staining (Fig. 7). As reported by others, few cells in
developing zebrafish embryos undergo apoptosis. In unin-
jected embryos (Figs. 7A–I), almost all spinal cord neurons
undergoing apoptosis are sensory Rohon-Beard neurons. The
soma of these neurons lies in the dorsal spinal cord (white
arrows). In the region of motoneuron soma (marked between
dashed lines), only occasional apoptotic cells are ever found
and only in 48 and 72 h p.f. embryos (Fig. 7H; red arrow).
These neurons maybe the VaP, which undergoes developmen-
tally regulated cell death (Eisen et al., 1990).
In morpholino treated embryos, no enhanced cell death was
found in neurons of the spinal cord (Figs. 7J–R). Specific
scrutiny was given to hemisegments possessing CaP motoneur-
ons that failed to extend to the ventral target (marked with white
arrowheads in Figs. 7J, M, P). When apoptotic neurons were
found in the region of motoneuron soma these apoptotic
neurons never occurred in hemisegments possessing stalled CaPI) Uninjected embryos at indicated developmental time points were stained for
nal antibody. Up to 3 days p.f., there is little cell death in embryos. The region
l cord, almost all TUNEL-positive neurons are sensory Rohon-Beard neurons
lly, an apoptotic neuron (one in eight hemisegments) was present in the region of
as in panels A–I. There is no increased cell death associated with morpholino
ventral target is marked with a white arrowhead (J, M, P). Identical results were
all images, rostral is to the left, and dorsal is up.
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same as for uninjected embryos and is consistent with them
being VaP neurons. As with uninjected embryos, Rohon-Beardsensory neurons were the primary spinal cord neurons
undergoing apoptosis. Results identical to morpholino injection
were obtained upon expression of DN-STAT3 (not shown).
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Role of JAK/STAT in cell migration suggests a functional
mechanism in pathfinding
Both cell migration and neuronal pathfinding are similar in
that both are responses to extracellular guidance cues using
common signaling molecules. Thus, the function of STAT3 in
cell migration is enlightening in that it provides a possible
mechanism by which STAT3 functions in neuronal pathfinding.
In the zebrafish STAT3 signaling is required for migration of
anterior axial mesendoderm (Yamashita et al., 2002). STAT3
activation leads to increased Snail1 activity that in turn leads to
the epithelial-to-mesenchymal transition (EMT) of anterior
axial mesendoderm (Yamashita et al., 2004). EMT alters cell
adhesion and cytoskeletal structure required for planar cell
polarity of individual blastomeres that, in mass, give rise to the
bulk movements leading to extension of the anterior body axis.
In the absence of STAT3 mesendodermal migration is greatly
reduced, but not eliminated. In this role, STAT3 functions as a
competence factor defining the mesenchymal nature of anterior
axial mesendoderm and, therefore, the responsive population
capable of migrating toward an unknown convergence-
extension chemokine.
The role of JAK/STAT signaling in the migration of border
cells in the Drosophila ovary is similar to the function in
zebrafish gastrulation (Silver and Montell, 2001; Beccari et al.,
2002; Ghiglione et al., 2002). In this system, STAT signaling
again functions as a competence factor facilitating migratory
responses to a trophic signal, in this case PVF (Silver and
Montell, 2001; Beccari et al., 2002; Ghiglione et al., 2002; Xi et
al., 2003). As in the zebrafish, cell migration is not completely
eliminated in the absence of JAK/STAT signaling; rather,
signaling promotes cell migration. As a competence factor,
JAK/STAT enhances trophic responsiveness by executing
changes in gene expression altering cell adhesion and
cytoskeletal dynamics (Silver and Montell, 2001; Silver et al.,
2005).
Like JAK/STAT, the transcription factors SRF and MAL
have similar functions in border cell migration (Somogyi and
Rorth, 2004). They appear to function like JAK/STAT,
activating genes regulating actin dynamics thereby facilitating
migration. Recently, SRF and MAL have been shown to
function similarly in neuronal pathfinding (Knoll et al., 2006).
The general function of JAK/STAT signaling in cell migration is
that of a competence factor and the role of STAT3 signaling in
neuronal pathfinding is consistent with the same function.
STAT3 facilitates pathfinding
Three methods for abrogation of STAT3 signaling lead to
CaP motoneuron pathfinding defects: morpholino knockdown,
injection of blocking peptides, and dominant negative expres-
sion. The specific requirement for STAT3 is shown by the
ability to rescue morpholino induced defects by reintroduction
of wild-type STAT3. Consistent with a STAT3 requirement,
STAT3 is activated in CaP motoneurons. Cell transplants showthat STAT3 functions cell autonomously and in situ hybridiza-
tion and TUNEL staining have ruled out pathfinding defects due
to improper motoneuron specification or cell death. For CaP
motoneuron pathfinding, results suggest that JAK1 kinase may
not be required as an upstream activator of STAT3 in this
developmental context. However, one of the other three JAK
kinase members may be utilized.
Though none of the methods I used may completely
eliminate all STAT3 signaling, in no case was it possible to
inhibit more than half of CaP motoneuron axons in their
projection along the ventral path. Morpholino injection has the
most pronounced affect upon CaP pathfinding as well as upon
the migration of anterior axial mesendoderm, compared to
dominant negative expression and blocking peptides. This
varying degree of affect can be explained by varying degrees of
STAT3 inhibition. Interestingly, no zebrafish pathfinding
mutants are completely penetrant, even null alleles. My findings
agree with the suggestion of Zeller et al. (2002), that CaP
motoneuron pathfinding requires multiple guidance cues that
appear in sum to direct pathfinding.
STAT3 and the regulation of axon branching
Not only is STAT3 utilized for CaP motoneuron pathfinding,
but constitutive activation indicates that STAT3 regulates
branch formation. At 27 h p.f., the CaP motoneuron axon
possesses few branches, however, in the presence of activated
STAT3, these axons have four times the normal number of
branches. Interestingly these branches are normally seen in 48-
h p.f. embryos. Branches at 27 h p.f. may represent a precocious
response to neurotrophic signals that illicit or stabilize branch
formation.
Support for this permissive function comes from observa-
tions of secondary motoneurons. These neurons exist as three
motoneuron subtypes (RoP-like, MiP-like, and CaP-like) and
innervate the same muscle groups as their cognate primaries,
but do so at a later time. Normally CaP-like motoneurons do not
extensively branch across the muscle surface like the primary
motoneurons and the presence of constitutively active STAT3 in
secondary motoneurons does not induce branching as it does in
primary motoneurons (not shown). This suggests that STAT3
does not act as a general branch-inducing factor; if branching
does not happen as in the case of the secondary motoneurons,
branches are not induced. While STAT3 activation has no affect
upon branching of the CaP-like motoneuron it does lead to
formation of MiP-like projecting collaterals, as it does in the
CaP motoneuron (see below).
STAT3 and the selection of target choice
Expression of constitutively active STAT3 in CaP motoneur-
ons frequently leads to ectopic collateral formation that follows
the dorsal pathway, a trajectory normally explored by the MiP
motoneuron. Of particular note is the fact that collateral
formation does not occur at random positions off of the main
axonal trunk and projection of these collaterals is not random.
Ectopic collaterals always follow the same path, a dorsal–
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Neurotrophic signals and/or an ECM pathway probably
demarcate this dorsal pathway. While the CaP motoneuron
normally is not responsive to this signal, the MiP motoneuron
responds robustly by sending a collateral along this path. If
STAT3 enhances neurotrophic competence, then constitutive
activation may enhance dorsal signals/ECM interactions
sufficient to initiate or stabilize a CaP motoneuron collateral
along this ectopic trajectory.
Interestingly CaP-like secondary motoneurons show an
identical affect, with an ectopic collateral projecting along the
MiP/MiP-like trajectory (not shown). Both exuberant branching
and ectopic collateral formation may result from enhanced
responses to neurotrophic/ECM signals that are normally
present. STAT3 redefines CaP/CaP-like axons as a responding
population to dorsal guidance cues. For an unknown reason,
only CaP/CaP-like neurons respond in this way, while the other
motoneuron subtypes/subtype-like do not.
Potential neurotrophic and LIM-HD activators of CaP
motoneuron STAT3
Original evidence that warranted my investigation of STAT3
in motoneuron pathfinding is the existence of numerous muscle
derived neurotrophic factors activating STAT3. A neurotrophic
factor signaling through STAT3 could facilitate/potentiate
responses to this guidance factor or responses originating
from other signals.
A candidate neurotrophic factor that could attract CaP
motoneurons as well as activate STAT3 is HGF/scatter factor.
The receptor for HGF/SF, c-Met, is known to activate STAT3
(Boccaccio et al., 1998), and HGF/SF is a neurotrophic factor
for innervating motoneurons (Ebens et al., 1996; reviewed in
Birchmeier et al., 2003). The presence of c-Met in CaP
motoneurons at the time of pathfinding supports a role for HGF/
SF in CaP pathfinding, while neither the RoP nor MiP expresses
this receptor (Segawa et al., 2001). Also, HGF/SF is expressed
by zebrafish somitic muscle at the time of pathfinding (Haines
et al., 2004). HGF is tethered to the extracellular matrix of
muscle (reviewed in Birchmeier et al., 2003). The work of
Zhang et al. (2003) suggests that pathfinding of the CaP
motoneuron along the ventral path is dependent upon unknown
extracellular matrix components. HGF/SF could be the factor.
Recently GDNF has been shown to regulate dorsal–ventral
pathway choice of limb motoneurons. The GDNF receptor, c-
Ret, activates STAT3 and is expressed by the zebrafish CaP
motoneuron (Bisgrove et al., 1997; Schuringa et al., 2001;
Kramer et al., 2006). GDNF is also a possible neurotrophic
candidate.
Other possible neurotrophic factors are members of the
CNTF family. Members of this neurotrophic group (CLC, CLC-
CLF dimer, CT, NP) and the co-ligand CNTFα-receptor activate
STAT3 (Lesser and Lo, 2000; Derouet et al., 2004). Mouse
knockouts of the CNTFα receptor, CLF, and CT display a
pronounced reduction in the number of motoneurons at birth
(DeChiara et al., 1995; Oppenheim et al., 2001; Forger et al.,
2003) consistent with a pathfinding defect preventing exposureto target derived trophic factors. NP, CT, CLC, CLF, and the
CNTFα receptor are highly expressed by mouse embryonic
skeletal muscle and tethered to its surface (Helgren et al., 1994;
Pennica et al., 1996; Forger et al., 2003; Derouet et al., 2004).
Recently, Cxcl12 (SDF)-Cxcr4 signaling has been shown to
direct the initial trajectory of mammalian motoneurons
(Lieberam et al., 2005). The receptor, Cxcr4, activates multiple
members of the JAK kinase family leading to STAT3
phosphorylation (Vila-Coro et al., 1999; Soriano et al., 2002;
Ahr et al., 2005; Lieberam et al., 2005).
In addition to ligand induced STAT3 activation, a mecha-
nism for ligand/receptor-independent activation also exists (Hao
et al., 2005). LIM-HD proteins function as adaptors linking
STAT3 to JAK kinases. So far two members of the JAK kinase
family have been shown to bind LIM domains, JAK1 and
JAK2. However, the other two members of the JAK family may
interact as well. In the experiments reported herein, only JAK1
was inactivated and does not appear to be required. Other JAK
kinases may function in zebrafish CaP motoneurons. In addition
to bringing STAT3 into close opposition with JAK kinases, LIM
domains elevate the kinase activity of JAKs and potentiate
ligand-induced phosphorylation of STAT3, for example, by
HGF/SF, CNTF members, or Cxcl12. LIM-HD proteins are
present in pathfinding motoneurons and their function may be to
activate or enhance STAT3 activation.
The role of STAT3 in pathfinding and regeneration of other
animals
The findings reported here raise the question: is STAT3
utilized for neuronal pathfinding in other organisms, especially
mammals? Except for a single report (Ihara et al., 1997),
numerous tissue culture studies, all utilizing mammalian cells,
indicate that STAT3 promotes neurite outgrowth (Wu and
Bradshaw, 1996a,b, 2000; Fricker et al., 2005; He et al., 2005;
Kretz et al., 2005; Taylor et al., 2005). Particularly interesting is
the finding that STAT3 and the similar transcription factor
STAT1, another member of the STAT family, have opposing
affects upon neurite outgrowth (Wu and Bradshaw, 2000).
STAT3 and STAT1 can form homodimers or heterodimers with
each other. The DNA binding sequence recognized by these
combinations is different. Thus, different genes are activated
depending on the relative ratio of the two transcription factors.
Transcription factor complexes possessing STAT1 inhibit
neurite outgrowth while STAT3 homodimers promote out-
growth (Wu and Bradshaw, 2000). If neurite outgrowth and
neuronal pathfinding require the activation of a similar set of
genes, then studies from mammalian tissue culture suggest that
STAT3 may play a role in mammalian neuronal pathfinding.
With regard to STAT3/STAT1 ratios in the zebrafish, STAT1 is
not present until the sixth day of development (Oates et al.,
1999); thus, neurite-inhibitory STAT dimers are not present
during the period of zebrafish development when the majority
of neural connections are made.
In the mouse, STAT3 has been eliminated in neurons using
neurospecific Cre expression (Schweizer et al., 2002). Though
neuronal pathfinding was not investigated, for example, through
134 G. Conway / Developmental Biology 296 (2006) 119–136retrograde labeling, no obvious developmental or behavioral
defects were noted. If STAT3 functions as a competence factor
resulting in less than complete penetrance, any resulting
behavioral deficits might be insufficient to have compelled a
retrograde labeling study. Because pathfinding has never been
investigated in STAT3 conditional knockouts, it is unknown if
STAT3 functions in neuronal pathfinding of the mouse.
In every neural injury model, STAT3 is rapidly and robustly
activated (reviewed in Liu and Snider, 2001; Snider et al.,
2002). Because of this, neural regeneration has been investi-
gated in conditional STAT3 knockout mice (Schweizer et al.,
2002). The process of neural regeneration is a process that one
might view as similar or in many ways analogous to pathfinding
(reviewed in Snider et al., 2002). Neuronal regeneration was
investigated using the facial motoneuron transection model and
STAT3 found to be required for motoneuron survival after
injury. This requirement could be due to a direct role in
preventing apoptosis, or alternatively or in combination, STAT3
may be may be required for reinnervation. These reconnections
would in turn provide target derived trophic support.
Interestingly, the transcription factors c-Jun and CREB,
cofactors that physically interact with STAT3 at many
promoter sites and are required for maximal transactivation
(Kojima et al., 1996; Ichiba et al., 1998; Zhang et al., 1999;
Wang et al., 2005), are coordinately activated with STAT3
following neural injury (Herdegen et al., 1997; Herdegen and
Leah, 1998; Lonze and Ginty, 2002; Qiao and Vizzard, 2005).
These co-factors are required for target reinnervation during
neural regeneration (Schweizer et al., 2002; Gao et al., 2004;
Raivich et al., 2004; Zhou et al., 2004) and as shown for
CREB also required for neuronal pathfinding (Lonze et al.,
2002). Axon reinnervation and pathfinding may require the
expression of a common set of activated genes. My finding
that STAT3 facilitates developmental pathfinding suggests that
during neural regeneration STAT3 may facilitate reinnervation
in the same way that cofactors c-Jun and CREB (activated by
c-AMP) facilitate this process. If neural death is prevented, for
example, using STAT3−/−/Bax−/− mice, a role in reinnervation
may be revealed.
Summary
The results presented here are the first report of a role for
STAT3 in neuronal pathfinding and are consistent with STAT3
facilitating this process. In the absence of STAT3, half of CaP
motoneuron axons fail to pathfind along their normal ventral
path. On the other hand, constitutively active STAT3 induces
precocious branching and ectopic collateral formation, redefin-
ing CaP axons as a responding population to dorsal guidance
cues. Ectopic collaterals form in a nonrandom process,
branching off of the main axon trunk at a normal branching
site and projecting along a normal motoneuron trajectory, even
though this branching site and the ectopic path that is followed
are normally used by another motoneuron. STAT3 has been
shown to facilitate chemotactic responses to guidance cues in
nonneural cells, the results presented here extend this function
to pathfinding neurons as well.Acknowledgments
I thank Sigrid Reinsch (NASA Ames Research Center) and
members of her laboratory for their helpful advice on
experimental design and the manuscript. Thank you to the
instructors and fellow students of the 2001 MBL Neural
Development and Genetics of Zebrafish Course. The NASA
Fundamental Biology program funded this work.
References
Ahr, B., Denizot, M., Robert-Hebmann, V., Brelot, A., Biard-Piechaczyk, M.,
2005. Identification of the cytoplasmic domains of CXCR4 involved in Jak2
and STAT3 phosphorylation. J. Biol. Chem. 280, 6692–6700.
Appel, B., Korzh, V., Glasgow, E., Thor, S., Edlund, T., Dawid, I.B., Eisen, J.S.,
1995. Motoneuron fate specification revealed by patterned LIM homeobox
gene expression in embryonic zebrafish. Development 121, 4117–4125.
Arimura, N., Kaibuchi, K., 2005. Key regulators in neuronal polarity. Neuron
48, 881–884.
Beccari, S., Teixeira, L., Rorth, P., 2002. The JAK/STAT pathway is required for
border cell migration during Drosophila oogenesis. Mech. Dev. 111,
115–123.
Becker, S., Groner, B., Muller, C.W., 1998. Three-dimensional structure of the
Stat3beta homodimer bound to DNA. Nature 394, 145–151.
Birchmeier, C., Birchmeier, W., Gherardi, E., Vande Woude, G.F., 2003. Met,
metastasis, motility and more. Nat. Rev., Mol. Cell Biol. 4, 915–925.
Bisgrove, B.W., Raible, D.W., Walter, V., Eisen, J.S., Grunwald, D.J., 1997.
Expression of c-ret in the zebrafish embryo: potential roles in motoneuronal
development. J. Neurobiol. 33, 749–768.
Boccaccio, C., Ando, M., Tamagnone, L., Bardelli, A., Michieli, P., Battistini,
C., Comoglio, P.M., 1998. Induction of epithelial tubules by growth factor
HGF depends on the STAT pathway. Nature 391, 285–288.
Bromberg, J., Darnell Jr., J.E., 2000. The role of STATs in transcriptional control
and their impact on cellular function. Oncogene 19, 2468–2473.
Bromberg, J.F., Horvath, C.M., Besser, D., Lathem, W.W., Darnell Jr., J.E.,
1998. Stat3 activation is required for cellular transformation by v-src. Mol.
Cell. Biol. 18, 2553–2558.
Bromberg, J.F., Wrzeszczynska, M.H., Devgan, G., Zhao, Y., Pestell, R.G.,
Albanese, C., Darnell Jr., J.E., 1999. Stat3 as an oncogene. Cell 98,
295–303.
Brose, K., Tessier-Lavigne, M., 2000. Slit proteins: key regulators of axon
guidance, axonal branching, and cell migration. Curr. Opin. Neurobiol. 10,
95–102.
Caton, A., Hacker, A., Naeem, A., Livet, J., Maina, F., Bladt, F., Klein, R.,
Birchmeier, C., Guthrie, S., 2000. The branchial arches and HGF are
growth-promoting and chemoattractant for cranial motor axons. Develop-
ment 127, 1751–1766.
Charron, F., Tessier-Lavigne, M., 2005. Novel brain wiring functions for
classical morphogens: a role as graded positional cues in axon guidance.
Development 132, 2251–2262.
Conway, G., Margoliath, A., Wong-Madden, S., Roberts, R.J., Gilbert, W.,
1997. Jak1 kinase is required for cell migrations and anterior specification in
zebrafish embryos. Proc. Natl. Acad. Sci. U. S. A. 94, 3082–3087.
Conway, G., Torrejon, M., Lin, S., Reinsch, S., 2006. Fluorescent tagged
analysis of neural gene function using mosaics in zebrafish and Xenopus
laevis. Brain Res. 1070, 150–159.
DeChiara, T.M., Vejsada, R., Poueymirou, W.T., Acheson, A., Suri, C.,
Conover, J.C., Friedman, B., McClain, J., Pan, L., Stahl, N., et al., 1995.
Mice lacking the CNTF receptor, unlike mice lacking CNTF, exhibit
profound motor neuron deficits at birth. Cell 83, 313–322.
Derouet, D., Rousseau, F., Alfonsi, F., Froger, J., Hermann, J., Barbier, F.,
Perret, D., Diveu, C., Guillet, C., Preisser, L., Dumont, A., Barbado, M.,
Morel, A., deLapeyriere, O., Gascan, H., Chevalier, S., 2004.
Neuropoietin, a new IL-6-related cytokine signaling through the ciliary
neurotrophic factor receptor. Proc. Natl. Acad. Sci. U. S. A. 101,
4827–4832.
135G. Conway / Developmental Biology 296 (2006) 119–136Ebens, A., Brose, K., Leonardo, E.D., Hanson Jr., M.G., Bladt, F., Birchmeier,
C., Barres, B.A., Tessier-Lavigne, M., 1996. Hepatocyte growth factor/
scatter factor is an axonal chemoattractant and a neurotrophic factor for
spinal motor neurons. Neuron 17, 1157–1172.
Eisen, J.S., Pike, S.H., Romancier, B., 1990. An identified motoneuron with
variable fates in embryonic zebrafish. J. Neurosci. 10, 34–43.
Forger, N.G., Prevette, D., deLapeyriere, O., de Bovis, B., Wang, S., Bartlett, P.,
Oppenheim, R.W., 2003. Cardiotrophin-like cytokine/cytokine-like factor 1
is an essential trophic factor for lumbar and facial motoneurons in vivo.
J. Neurosci. 23, 8854–8858.
Fricker, A.D., Rios, C., Devi, L.A., Gomes, I., 2005. Serotonin receptor
activation leads to neurite outgrowth and neuronal survival. Brain Res. Mol.
Brain Res. 138, 228–235.
Gao, Y., Deng, K., Hou, J., Bryson, J.B., Barco, A., Nikulina, E., Spencer, T.,
Mellado, W., Kandel, E.R., Filbin, M.T., 2004. Activated CREB is sufficient
to overcome inhibitors in myelin and promote spinal axon regeneration in
vivo. Neuron 44, 609–621.
Ghiglione, C., Devergne, O., Georgenthum, E., Carballes, F., Medioni, C.,
Cerezo, D., Noselli, S., 2002. The Drosophila cytokine receptor Domeless
controls border cell migration and epithelial polarization during oogenesis.
Development 129, 5437–5447.
Haines, L., Neyt, C., Gautier, P., Keenan, D.G., Bryson-Richardson, R.J.,
Hollway, G.E., Cole, N.J., Currie, P.D., 2004. Met and Hgf signaling
controls hypaxial muscle and lateral line development in the zebrafish.
Development 131, 4857–4869.
Hao, A., Novotny-Diermayr, V., Bian, W., Lin, B., Lim, C.P., Jing, N., Cao, X.,
2005. The LIM/homeodomain protein Islet1 recruits Janus tyrosine kinases
and signal transducer and activator of transcription 3 and stimulates their
activities. Mol. Biol. Cell 16, 1569–1583.
He, J.C., Gomes, I., Nguyen, T., Jayaram, G., Ram, P.T., Devi, L.A., Iyengar, R.,
2005. The G alpha(o/i)-coupled cannabinoid receptor-mediated neurite
outgrowth involves Rap regulation of Src and Stat3. J. Biol. Chem. 280,
33426–33434.
Hedgecock, E.M., Culotti, J.G., Hall, D.H., 1990. The unc-5, unc-6, and unc-40
genes guide circumferential migrations of pioneer axons and mesodermal
cells on the epidermis in C. elegans. Neuron 4, 61–85.
Helgren, M.E., Squinto, S.P., Davis, H.L., Parry, D.J., Boulton, T.G., Heck, C.S.,
Zhu, Y., Yancopoulos, G.D., Lindsay, R.M., DiStefano, P.S., 1994. Trophic
effect of ciliary neurotrophic factor on denervated skeletal muscle. Cell 76,
493–504.
Herdegen, T., Leah, J.D., 1998. Inducible and constitutive transcription factors
in the mammalian nervous system: control of gene expression by Jun, Fos
and Krox, and CREB/ATF proteins. Brain Res. Brain Res. Rev. 28,
370–490.
Herdegen, T., Skene, P., Bahr, M., 1997. The c-Jun transcription factor—
Bipotential mediator of neuronal death, survival and regeneration. Trends
Neurosci. 20, 227–231.
Hou, S.X., Zheng, Z., Chen, X., Perrimon, N., 2002. The Jak/STAT pathway in
model organisms: emerging roles in cell movement. Dev. Cell 3, 765–778.
Ichiba, M., Nakajima, K., Yamanaka, Y., Kiuchi, N., Hirano, T., 1998.
Autoregulation of the Stat3 gene through cooperation with a cAMP-
responsive element-binding protein. J. Biol. Chem. 273, 6132–6138.
Ihara, S., Nakajima, K., Fukada, T., Hibi, M., Nagata, S., Hirano, T., Fukui, Y.,
1997. Dual control of neurite outgrowth by STAT3 andMAP kinase in PC12
cells stimulated with interleukin-6. EMBO J. 16, 5345–5352.
Inoue, A., Takahashi, M., Hatta, K., Hotta, Y., Okamoto, H., 1994.
Developmental regulation of islet-1 mRNA expression during neuronal
differentiation in embryonic zebrafish. Dev. Dyn. 199, 1–11.
Ishii, N., Wadsworth, W.G., Stern, B.D., Culotti, J.G., Hedgecock, E.M., 1992.
UNC-6, a laminin-related protein, guides cell and pioneer axon migrations in
C. elegans. Neuron 9, 873–881.
Jowett, T., 1999. Analysis of protein and gene expression. Methods Cell Biol.
59, 63–85.
Kane, D.A., Kishimoto, Y., 2002. Cell Labeling and Transplantation
Techniques. Oxford Univ. Press, Oxford.
Kaptein, A., Paillard, V., Saunders, M., 1996. Dominant negative stat3 mutant
inhibits interleukin-6-induced Jak-STAT signal transduction. J. Biol. Chem.
271, 5961–5964.Knoll, B., Kretz, O., Fiedler, C., Alberti, S., Schutz, G., Frotscher, M.,
Nordheim, A., 2006. Serum response factor controls neuronal circuit
assembly in the hippocampus. Nat. Neurosci. 9, 195–204.
Kojima, H., Nakajima, K., Hirano, T., 1996. IL-6-inducible complexes on an IL-
6 response element of the junB promoter contain Stat3 and 36 kDa CRE-like
site binding protein(s). Oncogene 12, 547–554.
Kramer, E.R., Knott, L., Su, F., Dessaud, E., Krull, C.E., Helmbacher, F., Klein,
R., 2006. Cooperation between GDNF/Ret and ephrinA/EphA4 signals for
motor-axon pathway selection in the limb. Neuron 50, 35–47.
Kretz, A., Happold, C.J., Marticke, J.K., Isenmann, S., 2005. Erythropoietin
promotes regeneration of adult CNS neurons via Jak2/Stat3 and PI3K/AKT
pathway activation. Mol. Cell. Neurosci. 29, 569–579.
Lecomte, M.J., Basseville, M., Landon, F., Karpov, V., Fauquet, M., 1998.
Transcriptional activation of the mouse peripherin gene by leukemia
inhibitory factor: involvement of STAT proteins. J. Neurochem. 70,
971–982.
Lelievre, E., Plun-Favreau, H., Chevalier, S., Froger, J., Guillet, C., Elson, G.C.,
Gauchat, J.F., Gascan, H., 2001. Signaling pathways recruited by the
cardiotrophin-like cytokine/cytokine-like factor-1 composite cytokine:
specific requirement of the membrane-bound form of ciliary neurotrophic
factor receptor alpha component. J. Biol. Chem. 276, 22476–22484.
Lesser, S.S., Lo, D.C., 2000. CNTF II, I presume? Nat. Neurosci. 3, 851–852.
Lieberam, I., Agalliu, D., Nagasawa, T., Ericson, J., Jessell, T.M., 2005. A
Cxcl12-CXCR4 chemokine signaling pathway defines the initial trajectory
of mammalian motor axons. Neuron 47, 667–679.
Liu, R.Y., Snider, W.D., 2001. Different signaling pathways mediate
regenerative versus developmental sensory axon growth. J. Neurosci. 21,
RC164.
Liu, Y., Stein, E., Oliver, T., Li, Y., Brunken, W.J., Koch, M., Tessier-Lavigne,
M., Hogan, B.L., 2004. Novel role for Netrins in regulating epithelial
behavior during lung branching morphogenesis. Curr. Biol. 14, 897–905.
Lonze, B.E., Ginty, D.D., 2002. Function and regulation of CREB family
transcription factors in the nervous system. Neuron 35, 605–623.
Lonze, B.E., Riccio, A., Cohen, S., Ginty, D.D., 2002. Apoptosis, axonal growth
defects, and degeneration of peripheral neurons in mice lacking CREB.
Neuron 34, 371–385.
Niewiadomska, P., Godt, D., Tepass, U., 1999. DE-Cadherin is required for
intercellular motility during Drosophila oogenesis. J. Cell Biol. 144,
533–547.
Oates, A.C., Wollberg, P., Pratt, S.J., Paw, B.H., Johnson, S.L., Ho, R.K.,
Postlethwait, J.H., Zon, L.I., Wilks, A.F., 1999. Zebrafish stat3 is expressed
in restricted tissues during embryogenesis and stat1 rescues cytokine
signaling in a STAT1-deficient human cell line. Dev. Dyn. 215, 352–370.
Oppenheim, R.W., Wiese, S., Prevette, D., Armanini, M., Wang, S., Houenou,
L.J., Holtmann, B., Gotz, R., Pennica, D., Sendtner, M., 2001. Cardio-
trophin-1, a muscle-derived cytokine, is required for the survival of
subpopulations of developing motoneurons. J. Neurosci. 21, 1283–1291.
O'Shea, J.J., Gadina, M., Schreiber, R.D., 2002. Cytokine signaling in 2002:
new surprises in the Jak/Stat pathway. Cell 109, S121–S131 (Suppl.).
Pennica, D., Arce, V., Swanson, T.A., Vejsada, R., Pollock, R.A., Armanini, M.,
Dudley, K., Phillips, H.S., Rosenthal, A., Kato, A.C., Henderson, C.E.,
1996. Cardiotrophin-1, a cytokine present in embryonic muscle, supports
long-term survival of spinal motoneurons. Neuron 17, 63–74.
Plun-Favreau, H., Elson, G., Chabbert, M., Froger, J., deLapeyriere, O.,
Lelievre, E., Guillet, C., Hermann, J., Gauchat, J.F., Gascan, H., Chevalier,
S., 2001. The ciliary neurotrophic factor receptor alpha component induces
the secretion of and is required for functional responses to cardiotrophin-like
cytokine. EMBO J. 20, 1692–1703.
Qiao, L.Y., Vizzard, M.A., 2005. Spinal cord injury-induced expression of
TrkA, TrkB, phosphorylated CREB, and c-Jun in rat lumbosacral dorsal root
ganglia. J. Comp. Neurol. 482, 142–154.
Raivich, G., Bohatschek, M., Da Costa, C., Iwata, O., Galiano, M., Hristova, M.,
Nateri, A.S., Makwana, M., Riera-Sans, L., Wolfer, D.P., Lipp, H.P., Aguzzi,
A., Wagner, E.F., Behrens, A., 2004. The AP-1 transcription factor c-Jun is
required for efficient axonal regeneration. Neuron 43, 57–67.
Schuringa, J.J., Wojtachnio, K., Hagens, W., Vellenga, E., Buys, C.H., Hofstra,
R., Kruijer, W., 2001. MEN2A-RET-induced cellular transformation by
activation of STAT3. Oncogene 20, 5350–5358.
136 G. Conway / Developmental Biology 296 (2006) 119–136Schweizer, U., Gunnersen, J., Karch, C., Wiese, S., Holtmann, B., Takeda, K.,
Akira, S., Sendtner, M., 2002. Conditional gene ablation of Stat3 reveals
differential signaling requirements for survival of motoneurons during
development and after nerve injury in the adult. J. Cell Biol. 156, 287–297.
Segawa, H., Miyashita, T., Hirate, Y., Higashijima, S., Chino, N., Uyemura, K.,
Kikuchi, Y., Okamoto, H., 2001. Functional repression of Islet-2 by
disruption of complex with Ldb impairs peripheral axonal outgrowth in
embryonic zebrafish. Neuron 30, 423–436.
Senaldi, G., Varnum, B.C., Sarmiento, U., Starnes, C., Lile, J., Scully, S., Guo,
J., Elliott, G., McNinch, J., Shaklee, C.L., Freeman, D., Manu, F., Simonet,
W.S., Boone, T., Chang, M.S., 1999. Novel neurotrophin-1/B cell-
stimulating factor-3: a cytokine of the IL-6 family. Proc. Natl. Acad. Sci.
U. S. A. 96, 11458–11463.
Serafini, T., Kennedy, T.E., Galko, M.J., Mirzayan, C., Jessell, T.M., Tessier-
Lavigne, M., 1994. The netrins define a family of axon outgrowth-
promoting proteins homologous to C. elegans UNC-6. Cell 78, 409–424.
Serafini, T., Colamarino, S.A., Leonardo, E.D., Wang, H., Beddington, R.,
Skarnes, W.C., Tessier-Lavigne, M., 1996. Netrin-1 is required for
commissural axon guidance in the developing vertebrate nervous system.
Cell 87, 1001–1014.
Shen, Y., Devgan, G., Darnell Jr., J.E., Bromberg, J.F., 2001. Constitutively
activated Stat3 protects fibroblasts from serum withdrawal and UV-induced
apoptosis and antagonizes the proapoptotic effects of activated Stat1. Proc.
Natl. Acad. Sci. U. S. A. 98, 1543–1548.
Silver, D.L., Montell, D.J., 2001. Paracrine signaling through the JAK/STAT
pathway activates invasive behavior of ovarian epithelial cells in
Drosophila. Cell 107, 831–841.
Silver, D.L., Naora, H., Liu, J., Cheng, W., Montell, D.J., 2004. Activated signal
transducer and activator of transcription (STAT) 3: localization in focal
adhesions and function in ovarian cancer cell motility. Cancer Res. 64,
3550–3558.
Silver, D.L., Geisbrecht, E.R., Montell, D.J., 2005. Requirement for JAK/STAT
signaling throughout border cell migration inDrosophila. Development 132,
3483–3492.
Snider, W.D., Zhou, F.Q., Zhong, J., Markus, A., 2002. Signaling the pathway to
regeneration. Neuron 35, 13–16.
Somogyi, K., Rorth, P., 2004. Evidence for tension-based regulation of
Drosophila MAL and SRF during invasive cell migration. Dev. Cell 7,
85–93.
Soriano, S.F., Hernanz-Falcon, P., Rodriguez-Frade, J.M., De Ana, A.M.,
Garzon, R., Carvalho-Pinto, C., Vila-Coro, A.J., Zaballos, A., Balomenos,
D., Martinez, A.C., Mellado, M., 2002. Functional inactivation of CXC
chemokine receptor 4-mediated responses through SOCS3 up-regulation.
J. Exp. Med. 196, 311–321.
Takeda, K., Noguchi, K., Shi, W., Tanaka, T., Matsumoto, M., Yoshida, N.,
Kishimoto, T., Akira, S., 1997. Targeted disruption of the mouse Stat3 gene
leads to early embryonic lethality. Proc. Natl. Acad. Sci. U. S. A. 94,
3801–3804.
Taylor, C., Fricker, A.D., Devi, L.A., Gomes, I., 2005. Mechanisms of action of
antidepressants: from neurotransmitter systems to signaling pathways. Cell.
Signal. 17, 549–557.
Thor, S., Andersson, S.G., Tomlinson, A., Thomas, J.B., 1999. A LIM-
homeodomain combinatorial code for motor-neuron pathway selection.
Nature 397, 76–80.
Tokumoto, M., Gong, Z., Tsubokawa, T., Hew, C.L., Uyemura, K., Hotta, Y.,
Okamoto, H., 1995. Molecular heterogeneity among primary motoneuronsand within myotomes revealed by the differential mRNA expression of
novel islet-1 homologs in embryonic zebrafish. Dev. Biol. 171, 578–589.
Tsuchida, T., Ensini, M., Morton, S.B., Baldassare, M., Edlund, T., Jessell, T.M.,
Pfaff, S.L., 1994. Topographic organization of embryonic motor neurons
defined by expression of LIM homeobox genes. Cell 79, 957–970.
Vila-Coro, A.J., Rodriguez-Frade, J.M., Martin De Ana, A., Moreno-Ortiz,
M.C., Martinez, A.C., Mellado, M., 1999. The chemokine SDF-1alpha
triggers CXCR4 receptor dimerization and activates the JAK/STAT
pathway. FASEB J. 13, 1699–1710.
Wang, R., Cherukuri, P., Luo, J., 2005. Activation of Stat3 sequence-specific
DNA binding and transcription by p300/CREB-binding protein-mediated
acetylation. J. Biol. Chem. 280, 11528–11534.
Weinstein, B.M., 2005. Vessels and nerves: marching to the same tune. Cell 120,
299–302.
Wu, Y.Y., Bradshaw, R.A., 1996a. Induction of neurite outgrowth by
interleukin-6 is accompanied by activation of Stat3 signaling pathway in a
variant PC12 cell (E2) line. J. Biol. Chem 271, 13023–13032.
Wu, Y.Y., Bradshaw, R.A., 1996b. Synergistic induction of neurite outgrowth by
nerve growth factor or epidermal growth factor and interleukin-6 in PC12
cells. J. Biol. Chem. 271, 13033–13039.
Wu, Y.Y., Bradshaw, R.A., 2000. Activation of the Stat3 signaling pathway is
required for differentiation by interleukin-6 in PC12-E2 cells. J. Biol. Chem.
275, 2147–2156.
Xi, R., McGregor, J.R., Harrison, D.A., 2003. A gradient of JAK pathway
activity patterns the anterior–posterior axis of the follicular epithelium. Dev.
Cell 4, 167–177.
Yamashita, S., Miyagi, C., Carmany-Rampey, A., Shimizu, T., Fujii, R., Schier,
A.F., Hirano, T., 2002. Stat3 controls cell movements during zebrafish
gastrulation. Dev. Cell 2, 363–375.
Yamashita, S., Miyagi, C., Fukada, T., Kagara, N., Che, Y.S., Hirano, T., 2004.
Zinc transporter LIVI controls epithelial–mesenchymal transition in
zebrafish gastrula organizer. Nature 429, 298–302.
Yebra, M., Montgomery, A.M., Diaferia, G.R., Kaido, T., Silletti, S., Perez, B.,
Just, M.L., Hildbrand, S., Hurford, R., Florkiewicz, E., Tessier-Lavigne, M.,
Cirulli, V., 2003. Recognition of the neural chemoattractant Netrin-1 by
integrins alpha6beta4 and alpha3beta1 regulates epithelial cell adhesion and
migration. Dev. Cell 5, 695–707.
Zeller, J., Granato, M., 1999. The zebrafish diwanka gene controls an early step
of motor growth cone migration. Development 126, 3461–3472.
Zeller, J., Schneider, V., Malayaman, S., Higashijima, S., Okamoto, H., Gui, J.,
Lin, S., Granato, M., 2002. Migration of zebrafish spinal motor nerves into
the periphery requires multiple myotome-derived cues. Dev. Biol. 252,
241–256.
Zhang, X., Wrzeszczynska, M.H., Horvath, C.M., Darnell Jr., J.E., 1999.
Interacting regions in Stat3 and c-Jun that participate in cooperative
transcriptional activation. Mol. Cell. Biol. 19, 7138–7146.
Zhang, X.F., Wang, J.F., Matczak, E., Proper, J.A., Groopman, J.E., 2001. Janus
kinase 2 is involved in stromal cell-derived factor-1alpha-induced tyrosine
phosphorylation of focal adhesion proteins and migration of hematopoietic
progenitor cells. Blood 97, 3342–3348.
Zhang, F., Li, C., Halfter, H., Liu, J., 2003. Delineating an oncostatin M-
activated STAT3 signaling pathway that coordinates the expression of genes
involved in cell cycle regulation and extracellular matrix deposition of MCF-
7 cells. Oncogene 22, 894–905.
Zhou, F.Q., Walzer, M.A., Snider, W.D., 2004. Turning on the machine: genetic
control of axon regeneration by c-Jun. Neuron 43, 1–2.
